Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Gavvovidis, Ioannis Dr. (1) Kieback, Elisa Dr. (1) Leisegang, Matthias Dr. (4) Lorenz, Felix Dr. (3) Poncette, Lucia (1) Uckert, Wolfgang Prof. Dr. (10) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Kettenmann, Helmut Prof. Dr. (1) Bioinformatics (1) Biologie maligner Lymphome (11) Experimentelle Genetik von Herz- Kreislauferkrankungen (1) Genomics (1) Molekulare Immunologie und Gentherapie (14) Molekulare Immuntherapie (3) (-) Molekulare Zellbiologie und Gentherapie (6) Proteom Dynamik (1) Proteomics (1) Signaltransduktion in Tumorzellen (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Tumorgenetik und zelluläre Stressantworten (1) Zelluläre Neurowissenschaften (28) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (2) 2010 (1) (-) 2011 (3) 2014 (1) (-) 2015 (2) 2016 (2) 2017 (1) 2018 (1) (-) 2019 (1) 6 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Kettenmann, Helmut Prof. Dr.Molekulare Zellbiologie und Gentherapie201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. Juni 2011 in Cell Calcium Transmitter- and hormone-activated Ca(2+) responses in adult microglia/brain macrophages in situ recorded after viral transduction of a recombinant Ca(2+) sensor S. Seifert M. Pannell W. Uckert K. Faerber H. Kettenmann 15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. Juni 2011 in Cell Calcium Transmitter- and hormone-activated Ca(2+) responses in adult microglia/brain macrophages in situ recorded after viral transduction of a recombinant Ca(2+) sensor S. Seifert M. Pannell W. Uckert K. Faerber H. Kettenmann
15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
